--News Direct--
Contact Details
Matt Riley - Head of Investor Relations & Corporate Communications
Company Website
https://agiletherapeutics.com/
View original content to download multimedia: https://newsdirect.com/news/nasdaq-agrx-agile-therapeutics-anticipates-increased-growth-in-q3-of-2022-580154414
